AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
AcelRx Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: May 14, 2019
AcelRx Pharmaceuticals reported fiscal year 2018 executive compensation information on May 14, 2019.
In 2018, five executives at AcelRx Pharmaceuticals received on average a compensation package of $1M, a 19% increase compared to previous year.
Average pay of disclosed executives at AcelRx Pharmaceuticals
Vincent J. Angotti, Chief Executive Officer, received $1.7M in total, which decreased by 26% compared to 2017. 46% of Angotti's compensation, or $798K, was in option awards. Angotti also received $330K in non-equity incentive plan, $600K in salary, as well as $11K in other compensation.
For fiscal year 2018, the median employee pay was $328,891 at AcelRx Pharmaceuticals. Therefore, the ratio of Vincent J. Angotti's pay to the median employee pay was 5 to one.
Pamela P. Palmer, Chief Medical Officer, received a compensation package of $1.1M, which increased by 22% compared to previous year. 44% of the compensation package, or $468K, was in salary.
Raffi Asadorian, Chief Financial Officer, earned $907K in 2018, a 50% increase compared to previous year.
Badri Dasu, Chief Engineering Officer, received $734K in 2018, which increases by 23% compared to 2017.
Lawrence G. Hamel, Chief Development Officer, earned $689K in 2018, a 16% increase compared to previous year.
Related executives
Vincent Angotti
AcelRx Pharmaceuticals
Chief Executive Officer
Raffi Asadorian
AcelRx Pharmaceuticals
Chief Financial Officer
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
Lawrence Hamel
AcelRx Pharmaceuticals
Former Chief Development Officer
You may also like
Source: SEC filing on May 14, 2019.